Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2012 | 09-2011 | 09-2010 | 09-2009 | 09-2008 | |
| Sales | 172,712 | 158,836 | 143,000 | 148,274 | 139,639 |
| Cost of Goods | 63,664 | 60,425 | 54,304 | 55,832 | 53,159 |
| Gross Profit | 109,048 | 98,411 | 88,696 | 92,442 | 86,480 |
| Operating Expenses | 60,416 | 58,803 | 47,862 | 44,495 | 42,289 |
| Operating Income | 49,296 | 40,033 | 41,138 | 48,779 | 44,350 |
| Other Income | 420 | 467 | 262 | 544 | 1,642 |
| Pre-tax Income | 49,716 | 40,500 | 41,400 | 49,323 | 45,992 |
| Income Tax | 16,345 | 13,669 | 14,753 | 16,564 | 15,790 |
| Net Income Continuous | 33,371 | 26,831 | 26,647 | 32,759 | 30,202 |
| Net Income | $33,371 | $26,831 | $26,647 | $32,759 | $30,202 |
| EPS Basic Total Ops | 0.81 | 0.66 | 0.66 | 0.81 | 0.75 |
| EPS Basic Continuous Ops | 0.81 | 0.66 | 0.66 | 0.81 | 0.75 |
| EPS Diluted Total Ops | 0.80 | 0.65 | 0.65 | 0.80 | 0.74 |
| EPS Diluted Continuous Ops | 0.80 | 0.65 | 0.65 | 0.80 | 0.74 |
| EBITDA(a) | $55,893 | $45,906 | $45,823 | $53,139 | $48,819 |